Lactic acid

Evofem Announces Issuance of U.S. Patent Covering Phexxi® Composition of Matter

Retrieved on: 
Friday, September 23, 2022
Securities Exchange Act of 1934, Health, Infection, Sex, Chlamydia, COVID-19, Woman, Human, FDA, Urinary tract infection, HIV, Gonorrhea, Company, Private Securities Litigation Reform Act, Pregnancy, History, Bacterial vaginosis, USPTO, Method, Orange Book, Reproductive health, Male, CDC, QIDP, Candidiasis, Patent, Annual report, Lactic acid, SAN, Citric acid, SEC, Orange, Birth control, Pharmaceutical industry, Animal, Lactic acid/citric acid/potassium bitartrate

SAN DIEGO, Sept. 23, 2022 /PRNewswire/ -- Evofem Biosciences (OTCPK: EVFM) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,439,610, which covers the composition of matter of Phexxi® (lactic acid, citric acid, potassium bitartrate).  

Key Points: 
  • 11,439,610, which covers the composition of matter of Phexxi (lactic acid, citric acid, potassium bitartrate).
  • "We are extremely pleased with the continued development of the Phexxi patent portfolio, which comprises more than 40 patents.
  • Top-line data from EVOGUARD, Evofem's registrational Phase 3 clinical trial evaluating Phexxi for these two potential new indications, are expected in mid-October.
  • Evofem now has the sole right in the United States to make, have made, market, and sell for any commercial purpose the composition of matter that comprises Phexxi.

Inventor of the Year Awarded to Developer of Phexxi®

Retrieved on: 
Monday, September 19, 2022
Securities Exchange Act of 1934, Therapy, Health, Infection, Sex, Chlamydia, COVID-19, Woman, FDA, Gonorrhea, Company, Private Securities Litigation Reform Act, Pregnancy, Reproductive health, STI, CDC, Annual report, Lactic acid, SAN, Citric acid, SEC, UIC, Birth control

SAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- Evofem Biosciences (OTCPK: EVFM) is pleased to congratulate University of Illinois Chicago (UIC) Professor Emeritus Donald Waller, Ph.D., on his recognition as Inventor of the Year for his role in developing novel therapeutics for the improvement of women's health, including Phexxi® (lactic acid, citric acid, potassium bitartrate).

Key Points: 
  • "We started by looking at natural defenses both against pregnancy and against pathogens, such as gonorrhea and other STIs.
  • Phexxi, the first innovation in the contraceptive category in decades, was approved by the FDA in 2020 for prevention of pregnancy.
  • Since Phexxi's initial launch, over 100,000 women have been prescribed Phexxi by nearly 21,000 health care providers.
  • Positive study outcomes would enable regulatory submissions and potential approval for prevention of these sexually transmitted infections (STIs) in 2023.

Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

Retrieved on: 
Friday, September 16, 2022
Securities Exchange Act of 1934, Sex, United States Department of Health and Human Services, Chlamydia, Human, Woman, FDA, Urinary tract infection, Treasury, Prescription, HIV, Company, Gonorrhea, Private Securities Litigation Reform Act, PBM, Birth control, Patient, Pregnancy, History, Bacterial vaginosis, Reproductive health, Human services, Male, Candidiasis, Annual report, New York State Department of Labor, Insurance, Lactic acid, SAN, Citric acid, SEC, Health, Health insurance, Healthcare, Lactic acid/citric acid/potassium bitartrate

SAN DIEGO, Sept. 16, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCPK: EVFM) today announced another new insurance win that gives millions of additional women access to Phexxi® (lactic acid, citric acid, potassium bitartrate) for the prevention of pregnancy.

Key Points: 
  • "Evofem's diligent efforts to expand access to Phexxi nationwide continue to pay off," said Saundra Pelletier, Chief Executive Officer of Evofem.
  • "We are thrilled that another highly respected national-level payer is now covering Phexxi, allowing women to fill their prescriptions immediately.
  • Evofem consistently engages with these payers to ensure they comply with these guidelines in covering Phexxi.
  • If you have a history of urinary tract problems that keep coming back, you should not use Phexxi.

Insights on the Bioplastic Composites Global Market to 2030 - Increasing Use of Bioplastic Composites in Consumer Goods is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 15, 2022
Recycling, Chemicals, Plastics, Environment, Manufacturing, Sustainability, Green Technology, Polymer, Seawater, Compact disc, Construction, Porter's five forces analysis, Electronics, AGC Aerospace & Defense, Risk, Recycling, PHA, Cellulose, Building & Construction Trades Council v. Associated Builders & Contractors of Massachusetts/Rhode Island, Inc., Growth, PLA, Natural Resources, PHB, Benchmarking, Bioplastic, Transport, Plastic, Chemical industry, Lactic acid, DVD, Water, Sewage, Metal, Soil, Housing, Thermoplastic, Polyhydroxyalkanoates

The growth of the global bioplastic composites market is driven by increase in use of bioplastic composites in consumer goods, packaging, and healthcare end-use industries.

Key Points: 
  • The growth of the global bioplastic composites market is driven by increase in use of bioplastic composites in consumer goods, packaging, and healthcare end-use industries.
  • These bioplastics replace metals in medical devices application, which is expected to provide the growth opportunity for global bioplastic composites market.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bioplastic composites market analysis from 2020 to 2030 to identify the prevailing bioplastic composites market opportunities.
  • The report includes the analysis of the regional as well as global bioplastic composites market trends, key players, market segments, application areas, and market growth strategies.

Moisturizing Is Vital to Healthy Skin

Retrieved on: 
Wednesday, September 7, 2022
Cream, Mineral oil, Liquid, Acne, Vitamin A, Safety, Vegetable, Lactic acid, Skin, Coenzyme Q10, Cosmetics, Absorption, Aloe, BOCA, Hyaluronic acid, Paraben, Valence (chemistry), Aloe vera, Vitamin E, Dietary supplement, Cholesterol, Nickel

BOCA RATON, Fla., Sept. 7, 2022 /PRNewswire/ -- Moisturizing brings out healthy-looking skin.

Key Points: 
  • Moisturizing decreases the chances of having dry or oily skin, which can develop into skin conditions, such as acne," said Gianluca Zin, founder of Venezia1920, a global beauty brand based in Venice, Italy.
  • "We have a full line of healthier skincare products, including our Super Moisturizing creams," Zin said.
  • "First, our Super Moisturizing Cream With Aloe Vera and Hyaluronic Acidis a highly moisturizing cream for younger skin that can help prevent dry or oily skin," Zin said.
  • Venezia 1920 also has Super Moisturizing Anti-Aging Cream with Tetravalent, which is for extremely dry skin.

LG Chem and ADM Launch Joint Ventures, Announce Intended Location for U.S. Production of Lactic Acid and Polylactic Acid Production

Retrieved on: 
Tuesday, August 16, 2022
Fitness & Nutrition, Chemicals, Plastics, Manufacturing, Food, Beverage, General Health, Health, Agriculture, Supply Chain Management, Retail, Natural Resources, Multimedia, Food security, Climate change, Industry, CEO, NYSE, Staten Island Economic Development Corporation, Technology, Growth, Plastic, SEC, Investment, USD, Cosmetics, Textile, Workforce, KRW, Biopolymer, Life, LG, Quality of life, EDGE, EDC, ADM, Food, Eye, Vaccine, Emergent BioSolutions, Fermentation, PLA, Lactic acid, Economic development, Federation, News, JV, Health, Economic development corporation, KRX, Solution, City, LG Chem, Renewable energy

Pending final investment decisions, the joint ventures have chosen Decatur, Illinois, U.S., as the location of their intended production facilities.

Key Points: 
  • Pending final investment decisions, the joint ventures have chosen Decatur, Illinois, U.S., as the location of their intended production facilities.
  • (Photo: Business Wire)
    The first joint venture, GreenWise Lactic, would produce up to 150,000 tons of high-purity corn-based lactic acid annually.
  • The second joint venture, LG Chem Illinois Biochem, would be majority-owned by LG Chem.
  • I am thrilled that LG Chem and ADM have chosen Decatur as home for their joint ventures, said Illinois Governor JB Pritzker.

Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast

Retrieved on: 
Monday, August 1, 2022
Treasury, Citric acid, Sex, United States Department of Health and Human Services, Woman, CEO, Chlamydia, Interview, Health, Roe, Micro-Cap, NASDAQ, News, Clinical trial, Gonorrhea, Human services, Review, Cost sharing, FDA, Company, Copley, Lactic acid, Indian stock exchange, Vertically transmitted infection, New York State Department of Labor, Reproductive health, Man, Hormone, OTC, Abortion, Birth control, Pharmaceutical industry

Phoenix, Arizona--(Newsfile Corp. - August 1, 2022) - The Stock Day Podcast welcomed Evofem Biosciences (NASDAQ: EVFM) ("the Company"), an innovator in women's sexual and reproductive health and the maker of hormone-free contraceptive Phexxi (lactic acid, citric acid and potassium bitartrate).

Key Points: 
  • Phoenix, Arizona--(Newsfile Corp. - August 1, 2022) - The Stock Day Podcast welcomed Evofem Biosciences (NASDAQ: EVFM) ("the Company"), an innovator in women's sexual and reproductive health and the maker of hormone-free contraceptive Phexxi (lactic acid, citric acid and potassium bitartrate).
  • Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies.
  • Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets.
  • The Stock Day Podcast is the number one radio show of its kind in America.

Recent Study Confirms Medical Findings on Effectiveness of Sustained Acoustic Medicine in Soft Tissue Healing and Recovery

Retrieved on: 
Thursday, July 28, 2022
ISO, Patient, Arthritis, Sports medicine, Skin, GLOBE, Injury, Physician, Torque, CGMP, RICE, Medicine, Health, Temperature, CEO, Vasodilation, Research, SAM, Diathermy, Meta-analysis, Therapeutic ultrasound, Lists of diseases, Adoption, Quality of life, Work, Physical medicine and rehabilitation, Systematic review, FDA, Lactic acid, Pain, Rehabilitation, Soft tissue injury, Medical device, Dietary supplement, Medical imaging, History of Sufism

"Sustained Acoustic Medicine treatment provides tissue heating and tissue recovery, improved patient function and reduction of pain," the authors found.

Key Points: 
  • "Sustained Acoustic Medicine treatment provides tissue heating and tissue recovery, improved patient function and reduction of pain," the authors found.
  • "When patients failed to respond to physical therapy, Sustained Acoustic Medicine proved to be a useful adjunct to facilitate healing and return to work.
  • As a non-invasive and non-narcotic treatment option with an excellent safety profile, Sustained Acoustic Medicine may be considered a good therapeutic option for practitioners."
  • "We hope to see sustained acoustic medicine widelyadopted by physicians and health care providers to help even more people with soft tissue healing, reduce pain, and get them back to normal daily activities even faster."

Asia Pacific Non-invasive Aesthetic Treatment Market Report 2022: Key Players Allergan, Merz Pharma, Johnson & Johnson and Others Driving 14.4% Annual Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 26, 2022
Surgery, Specialty, Other Health, Alternative Medicine, Fashion, Health, Cosmetics, Pharmaceutical, Retail, Skin, Industry, Procedure, Pigment, Day, Risk, Registrar, Country, Technology, Salicylic acid, Lactic acid, Acid, Lists of countries and territories, Cosmetics

This is a non-invasive procedure that restores luminosity, stimulates skin renewal and refreshes the skin.

Key Points: 
  • This is a non-invasive procedure that restores luminosity, stimulates skin renewal and refreshes the skin.
  • Also, this is among the most cost effective types of skin resurfacing with minimal to no downtime depending upon the choice of peel.
  • The aesthetic professionals provide controlled exfoliation of superficial layers of skin by the use of acids like lactic acid, salicylic acid & glycolic acid.
  • This treatment uses technology that combines the treated & untreated skin areas resulting in a faster recovery period.

Evofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry Recognition

Retrieved on: 
Tuesday, July 26, 2022
Male, House Rules, Awareness, Citric acid, Sex, Human, Industry, DTC, Woman, Partnership, Social media, SEC, History, SAN, Birth control, Health minister, Chlamydia, House, Private Securities Litigation Reform Act, Securities Exchange Act of 1934, Candidiasis, Urinary tract infection, Pregnancy, Emmy Awards, Quality of life, Clinical trial, Gonorrhea, YouTube, FDA, Company, Mediahub, Lactic acid, Reproductive health, Annual report, Internet celebrity, HIV, Bacterial vaginosis, Hormone, Lactic acid/citric acid/potassium bitartrate, Instagram, Twitter, Facebook

SAN DIEGO, July 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc.,(Nasdaq: EVFM)announced today a series of industry awards and recognition for the company's direct-to-consumer (DTC) advertising campaign, House Rules.

Key Points: 
  • SAN DIEGO, July 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc.,(Nasdaq: EVFM)announced today a series of industry awards and recognition for the company's direct-to-consumer (DTC) advertising campaign, House Rules.
  • House Rules features Emmy Award-winning spokeswoman Annie Murphy, who shares her personal birth control journey and the many reasons why Phexxi is the right contraceptive for her.
  • "I'm so proud of what we have been able to accomplish with House Rules," said Annie Murphy, acclaimed actress and Phexxi user and spokeswoman.
  • "The House Rules campaign and our partnership with Annie Murphy has furthered this goal by raising awareness of Phexxi with millions of women.